Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2023-09-26 Capital/Financing Update
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Plan połęczenia Mercator Medical S.A. z Brestia sp. z o.o.
Capital/Financing Update Classification · 98% confidence The document is titled "PLAN POŁĄCZENIA" (Merger Plan) between MERCATOR MEDICAL S.A. (acquiring company) and BRESTIA SP. Z O.O. (acquired company). It explicitly references Polish Commercial Companies Code articles (art. 498, 499, 516 KSH) related to company mergers, specifically an acquisition merger (łączenie się przejęcie). It includes the merger terms, details of the participating companies, and draft resolutions for the General Meeting and Shareholders' Meeting to approve the plan. This document is a core legal/transactional document detailing a corporate restructuring event (merger). This fits best under Capital/Financing Update (CAP) as mergers are significant capital structure changes, although it is more specific than a general financing announcement. However, given the provided definitions, 'CAP' (Capital/Financing Update) is the most appropriate category for a formal merger plan, which dictates the future capital structure and financing arrangements. It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement (RPA/RNS), as it contains the full substance of the transaction.
2023-09-26 Polish
Uzgodnienie i podanie do publicznej wiadomości planu połączenia w ramach przygotowania procesu połączenia Mercator Medical S.A. oraz Brestia sp. z o.o. - Content (PL)
M&A Activity Classification · 99% confidence The document text, written in Polish, explicitly discusses the agreement and signing of a 'plan połączenia' (merger plan) between the Issuer (Mercator Medical S.A.) and its subsidiary (Brestia sp. z o.o.). It details the legal basis (Polish Commercial Companies Code articles 492, 516), the simplified procedure due to 100% ownership, and the conditions for the merger (shareholder approval). This content directly relates to a corporate action involving a merger or takeover proposal. Therefore, the appropriate classification is M&A Activity (TAR). Although it mentions the plan is attached, the core subject is the merger itself, not just the announcement of a report's availability, making TAR more specific than RPA or RNS.
2023-09-26 Polish
Szacunkowe wyniki drugiego kwartału 2023 r. - Content (PL)
Earnings Release Classification · 100% confidence The document text is in Polish and presents preliminary, estimated consolidated financial results (revenues, EBITDA, net profit) for the second quarter of 2023, comparing them to previous periods. The key phrase is that these figures are 'wstępny i szacunkowy' (preliminary and estimated) and that the 'Skonsolidowany raport kwartalny' (Consolidated quarterly report) is 'w trakcie przygotowywania' (in preparation). Since this is the initial announcement of key quarterly financial highlights before the full report is ready, it fits the definition of an Earnings Release (ER). It is not the full Interim Report (IR) because it explicitly states the full report is still being prepared. Q2 2023
2023-09-19 Polish
Tekst jednolity statutu Spółki
Governance Information Classification · 98% confidence The document text is titled "STATUT SPÓŁKI AKCYJNEJ Mercator Medical Spółka Akcyjna" (Statute of Mercator Medical Joint Stock Company) and details the company's structure, including its purpose, capital, shares, and the composition and powers of its governing bodies (Management Board, Supervisory Board, General Meeting). This content is characteristic of a company's foundational legal document, which is often filed with regulatory bodies or provided to shareholders as part of corporate governance documentation. Among the provided codes, 'Governance Information' (CGR) is the most appropriate fit for a detailed Statute outlining corporate rules and structure, as opposed to a specific financial report (10-K, IR) or a meeting material (AGM-R, DEF 14A).
2023-08-28 Polish
Rejestracja zmian statutu Emitenta - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from the Management Board ('Zarząd') of Mercator Medical S.A. regarding the registration of amendments to the company's Articles of Association ('zmian statutu Spółki') by the National Court Register (KRS). The text details specific changes made to various paragraphs (§) of the statute, including changes to the share capital structure (though the total amount remains the same), voting rights associated with Series I shares, and rules governing the Supervisory Board ('Rada Nadzorcza'). Since the core content is the official registration of changes to the foundational corporate document (the statute), this relates to the company's structure and governance. While it touches upon capital structure (shares), the primary action is the formal registration of statutory changes. This type of filing, detailing fundamental corporate governance and structural amendments, aligns best with Governance Information (CGR) or potentially Capital/Financing Update (CAP) if the changes were purely financial. However, given the extensive detail on voting rights, board procedures, and the statute itself, CGR is the most appropriate fit among the provided options, as it reflects changes in internal rules and structure. It is not a standard financial report (10-K, IR) or an announcement of a report (RPA).
2023-08-28 Polish
Informacje udzielone akcjonariuszowi poza walnym zgromadzeniem, na podstawie art. 428 § 5 Kodeksu spółek handlowych - Content (PL)
AGM Information Classification · 98% confidence The document text is a detailed response from the Management Board of Mercator Medical S.A. to specific questions raised by a Shareholder during the Annual General Meeting (Zwyczajne Walne Zgromadzenie) held on June 23, 2023. The content addresses inquiries about related-party transactions, investment portfolios (stocks and FIZ units) as of year-end 2022, asset impairment in Thailand, trademark leasing details, and loan collateral specifics, referencing previous resolutions from the AGM on June 9, 2022. This structure—a formal reply to shareholder inquiries following an AGM—is characteristic of materials presented or distributed during or immediately after the Annual General Meeting. Therefore, it fits the 'AGM Information' category.
2023-07-07 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.